130 related articles for article (PubMed ID: 1774095)
1. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics.
Bhattacharya DK; Bhattacharjee S; De M; Lahiri P
Indian J Med Res; 1991 Dec; 94():430-2. PubMed ID: 1774095
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
4. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
5. HBV & HIV seropositivity in multi-transfused haemophilics & thalassaemics in eastern India.
De M; Banerjee D; Chandra S; Bhattacharya DK
Indian J Med Res; 1990 Jan; 91():63-6. PubMed ID: 2345033
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C seroprevalence in bone marrow transplant recipients and haemophiliacs.
Jackson SR; Carter JM; Jackson TW; Green GJ; Hawkins TE; Romeril K
N Z Med J; 1994 Jan; 107(970):10-1. PubMed ID: 7507581
[TBL] [Abstract][Full Text] [Related]
7. Sero-surveillance of transmissible hepatitis B & C viruses in asymptomatic HIV infection in haemophilics.
Sengupta B; De M; Lahiri P; Bhattacharya DK
Indian J Med Res; 1992 Nov; 95():256-8. PubMed ID: 1283980
[TBL] [Abstract][Full Text] [Related]
8. Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh.
Mollah AH; Nahar N; Siddique MA; Anwar KS; Hassan T; Azam MG
J Health Popul Nutr; 2003 Mar; 21(1):67-71. PubMed ID: 12751676
[TBL] [Abstract][Full Text] [Related]
9. Transfusion transmitted diseases in haemophilics from western India.
Ghosh K; Joshi SH; Shetty S; Pawar A; Chipkar S; Pujari V; Madkaikar M; Pathare AV; Jijina F; Mohanty D
Indian J Med Res; 2000 Aug; 112():61-4. PubMed ID: 11037680
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of anti-HCV in patients on long-term hemodialysis.
Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
[TBL] [Abstract][Full Text] [Related]
12. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
13. Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients.
Brenner B; Back D; Ben-Porath E; Hazani A; Martinowitz U; Tatarsky I
Isr J Med Sci; 1994 Dec; 30(12):886-90. PubMed ID: 8002269
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients.
Mansour AK; Aly RM; Abdelrazek SY; Elghannam DM; Abdelaziz SM; Shahine DA; Elmenshawy NM; Darwish AM
Hematol Oncol Stem Cell Ther; 2012; 5(1):54-9. PubMed ID: 22446611
[TBL] [Abstract][Full Text] [Related]
15. [A seroprevalence study of the hepatitis C virus among multiply transfused patients].
Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M
Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483
[TBL] [Abstract][Full Text] [Related]
16. Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients.
Ansari SH; Shamsi TS; Khan MT; Perveen K; Farzana T; Erum S; Ansari I
J Coll Physicians Surg Pak; 2012 Sep; 22(9):610-1. PubMed ID: 22980623
[TBL] [Abstract][Full Text] [Related]
17. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Monteleone PM; Andrzejewski C; Kelleher JF
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
